2021年Medicare医师费用表变化对关节置换外科医生的影响预测
本研究基于35名关节置换外科医生2019年10月至2020年10月的数据,比较2020与2021年Medicare医师费用表下工作RVU和报销额变化。结果显示手术报销减少远超办公室收入增加,总体报销下降9%;考虑到COVID-19救济法案延迟部分削减,预计净减少2.4%。
要点
- 2021年PFS导致关节置换手术报销减少,办公室报销增加但不足以抵消。
- 预计总体报销下降9%,考虑救济法案后净减少2.4%。
- 需进一步研究报销削减是否影响Medicare患者就医可及性。
核心结论
- 关节置换外科医生预计在2021年因PFS变化损失2.4%的Medicare报销。
研究设计与样本
- 回顾性查询本执业机构35名关节置换外科医生2019年10月至2020年10月的数据,比较2020与2021年PFS下工作RVU和报销差异。
主要发现
- 手术报销从530076美元降至464414美元,办公室报销从99456美元升至107374美元,总体报销从629532美元降至571788美元,减少9%。
临床怎么用
- 关节置换外科医生应预期Medicare报销下降,需关注对执业财务和患者就医可及性的潜在影响。
局限性
- 研究仅基于单一执业机构的35名外科医生数据,可能限制普遍性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Centers for Medicare and Medicaid Services 2021 Physician Fee Schedule (PFS) includes increases in office reimbursement but decreases in the valuation of total hip arthroplasty and total knee arthroplasty and the conversion factor. The purpose of this study was to determine the financial impact of these changes on arthroplasty surgeons. METHODS: We queried data for 35 arthroplasty surgeons within our practice from 10/2019 to 10/2020 and captured all office and arthroplasty-related surgical procedure codes. We compared the difference in both work relative value units (RVUs) and Medicare reimbursement by surgeon based on the current 2020 PFS to the 2021 changes. We also estimated the impact of several proposals to include office increases to the global surgical package for each code. RESULTS: While the mean per surgeon RVU amount for primary arthroplasty procedures will decrease (6267 vs 6,088, P = .78), the mean office work RVU (2755 vs 3,220, P = .16) will increase in 2021. However, the reduction in surgical reimbursement ($530,076 in 2020 to $464,414 in 2021) far exceeds the gains from the office ($99,456 vs $107,374), leading to an overall decrease in reimbursement ($629,532 vs $571,788), a reduction of 9%. The passage of the coronavirus disease 2019 relief bill delays many of the PFS cuts and will result in an overall reduction in reimbursement of 2.4% ($629,532 vs $612,475, P = .61). CONCLUSION: Arthroplasty surgeons are projected to lose 2.4% of Medicare reimbursement in 2021 with the changes in the Centers for Medicare and Medicaid Services PFS. Further study is needed to determine whether these cuts will limit access to care for Medicare patients.
引用
- Krueger CA, Courtney PM. Projections of the Impact to Arthroplasty Surgeons With Changes to the 2021 Medicare Physician Fee Schedule-A Looming Crisis of Access to Care? J Arthroplasty. 2021. PMID: 33812713. doi:10.1016/j.arth.2021.02.081
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。